A Phase 2 Study to Evaluate the Impact of MTP-131 (Bendavia™) on Skeletal Muscle Function in Elderly
Status:
Completed
Trial end date:
2016-07-06
Target enrollment:
Participant gender:
Summary
This was a Phase 2, randomized, double-blind, placebo-controlled study, enrolling 41 elderly
subjects with previous evidence of mitochondrial dysfunction to evaluate whether the
administration of MTP-131 (elamipretide) will change either hand skeletal muscle energetics
or muscle performance in age-related skeletal muscle mitochondrial dysfunction.